Furthermore, bioinformatics analyses of TCGA CRC patient cohorts confirm that a signature of high CEACAM1/low EPHA2/low CEACAM6 gene expression corresponds to significantly longer time to first recurrence/metastasis for CRC patients. This evidence concerns the gene CEACAM1 and colorectal carcinoma.